| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 128 |
| 1 | IPILIMUMAB | 82 |
| 2 | PEMBROLIZUMAB | 51 |
| 3 | CARBOPLATIN | 13 |
| 4 | PACLITAXEL | 8 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 8 |
| 6 | LEVOTHYROXINE SODIUM | 5 |
| 7 | LEVOTHYROXINE SODIUM ANHYDROUS | 5 |
| 8 | LENVATINIB | 4 |
| 9 | PEMETREXED DISODIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IPILIMUMAB | 82 | 0.0019 |
| 1 | NIVOLUMAB | 128 | 0.0013 |
| 2 | PENICILLIN G BENZATHINE | 1 | 0.0007 |
| 3 | NALDEMEDINE | 1 | 0.0006 |
| 4 | PEMBROLIZUMAB | 51 | 0.0005 |
| 5 | ALFUZOSIN HYDROCHLORIDE | 1 | 0.0004 |
| 6 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 7 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 8 | BINIMETINIB | 2 | 0.0003 |
| 9 | SILODOSIN | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 82 | 0.0017 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 128 | 0.0013 |
| 2 | Microtubule Inhibitor [EPC] | 8 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 13 | 0.0000 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 6 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 9 | Aldosterone Antagonist [EPC] | 2 | 0.0000 |